Therion Biologics Corporation

Patent Applications and Registrations

Patent applications and USPTO patent grants for Therion Biologics Corporation.The latest application filed is for "system for treating and preventing breast cancer".

Company Profile

0.12.3

Therion Biologics Corporation - 76 Rogers Street Cambridge MA
Therion Biologics Corporation - Cambridge MA
Therion Biologics Corporation -
Therion Biologics, Corp. - Cambridge MA
Therion Biologics Corporation - Cambrige MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
System for treating and preventing breast cancer App 20070110718 - Panicali; Dennis L. ; et al.	2007-05-17
Recombinant pox virus for immunization against MUC1 tumor-associated antigen Grant 7,118,738 - Schlom , et al. October 10, 2	2006-10-10
Transduced neoplastic cell preparations able to express T-cell costimulatory molecules B7.1, ICAM-1, and LFA-3 and induce immunostimulatory prophylactic and therapeutic anti-tumor effects in-vivo App 20040101522 - Panicali, Dennis L. ; et al.	2004-05-27
Recombinant pox virus for immunization against tumor-associated antigens Grant 6,699,475 - Panicali , et al. March 2, 2	2004-03-02
Recombinant pox virus for immunization against MUC1 tumor-associated antigen App 20030021770 - Schlom, Jeffrey ; et al.	2003-01-30
Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof Grant 6,319,496 - Panicali , et al. November 20, 2	2001-11-20
Generation of immune responses to prostate-specific antigen (PSA) Grant 6,165,460 - Schlom , et al. December 26, 2	2000-12-26
Self-assembled, defective, nonself-propagating viral particles Grant 6,051,410 - Mazzara , et al. April 18, 2	2000-04-18
Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof Grant 6,001,349 - Panicali , et al. December 14, 1	1999-12-14
Parvovirus empty capsids Grant 5,905,040 - Mazzara , et al. May 18, 1	1999-05-18
Self-assembled, defective, non-self-propagating lentivirus particles Grant 5,747,324 - Mazzara , et al. May 5, 1	1998-05-05
Self assembled defective non-self propagating lentiviral particles Grant 5,736,368 - Mazzara , et al. April 7, 1	1998-04-07
Methods of in vivo gene delivery Grant 5,656,465 - Panicali , et al. August 12, 1	1997-08-12
Recombinant pseudorabies virus Grant 5,242,829 - Panicali , et al. September 7, 1	1993-09-07
Recombinant fowlpox virus and recombination vector Grant 5,093,258 - Cohen , et al. March 3, 1	1992-03-03

Company Registrations

NCAGE Code	4LBA3	THERION BIOLOGICS CORPORATION
CAGE Code	4LBA3	THERION BIOLOGICS CORPORATION

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.